Denzil Bernard

Denzil Bernard is the Director of CADD at Atomwise. Denzil has previously worked as a Research Specialist at the University of Michigan, where they were responsible for the development of novel small molecule anti-cancer therapeutics. Denzil has also worked as a Research Fellow at the University of Michigan and as a Graduate Research Assistant at the University of Maryland. Denzil's research interests include the development of ligand-based delta opioid pharmacophores, the identification of new therapeutic targets, and the investigation of protein-ligand interactions.

Denzil Bernard has a PhD in Pharmaceutical Science from the University of Maryland Baltimore. Denzil also has a Bachelor of Pharmaceutical Sciences from the Institute of Chemical Technology Mumbai, India.

They work with Aram Davtyan - Senior Scientist, CADD, Ting-Rong Chern - Scientist II, CADD, and Teresa Palazzo - Scientist, CADD. Denzil Bernard reports to Kong Nguyen, Head of Computer Aided Drug Design.